Home
Scholarly Works
CTLA4 haploinsufficiency caused by a novel...
Journal article

CTLA4 haploinsufficiency caused by a novel heterozygous splice site mutation

Abstract

Background: Cytotoxic T lymphocyte-associated antigen-4 (CTLA4) haploinsufficiency is characterized by a variety of phenotypes, ranging from autoimmune disorders, enteropathy, fatal combined immunodeficiency, as well as lymphoproliferation and malignancy. Aim: To broaden the genotypic spectrum and clinical presentations of patients with CTLA4 variants. Methods: We evaluated a female patient with autoimmunity and lymphopenia. Immune workup and whole exome sequencing (WES) were performed. Results: The proband presented at 11 years of age with hypothyroidism and later developed Evans syndrome, alopecia, eczema, and lymphocytic interstitial pneumonia. Immune evaluation revealed T, B, and NK lymphopenia with normal humoral immunity. Following a negative genetic panel for autoimmune lymphoproliferative syndrome (ALPS), WES analysis identified a novel heterozygous intronic variant predicted in-silico to cause skipping of exon 2 of the CTLA4 gene. Conclusion: A novel heterozygous mutation in CTLA4 caused variable presentations of immune dysregulation, one of the hallmarks of CTLA4 haploinsufficiency. Statement of Novelty: We herein report a novel mutation in CTLA4 resulting in various features of autoimmunity.

Authors

Garkaby J; Fuentes LEA; Pachul JW; Merico D; Vong L

Journal

LymphoSign Journal, Vol. 9, No. 2, pp. 40–44

Publisher

LymphoSign Journal Limited Partnership

Publication Date

June 1, 2022

DOI

10.14785/lymphosign-2022-0004

ISSN

2292-5937
View published work (Non-McMaster Users)

Contact the Experts team